AbbVie announced that the U.S. Food and Drug Administration (FDA) has approved SKYRIZI® (risankizumab-rzaa) for children aged six and older living with moderate-to-severe plaque...
India's Union Health Ministry has revoked the manufacturing licences of Jackson Laboratories' facilities in Punjab and Himachal Pradesh following joint inspections by the Central...
In a major step toward trust-based governance, the Government of India has operationalised key reforms under the Jan VishwasAct, 2026. The initiative rationalises minor offences...